Related by context. All words. (Click for frequent words.) 69 receptor tyrosine kinase inhibitor 68 cytotoxic therapy 67 phase IIb clinical 66 proteasome inhibitor 66 immunomodulatory therapy 66 mTOR inhibitor 66 metastatic malignant melanoma 66 Onalta ™ 65 Bezielle 65 immune modulating 65 ALK inhibitor 65 BrachySil TM 65 paclitaxel poliglumex 65 IMA# 65 small molecule tyrosine 65 cediranib 65 HGS# 65 riociguat 65 Akt inhibitor 65 PDE4 inhibitor 65 imatinib therapy 65 Mipomersen 65 CCR5 antagonist 64 oral prodrug 64 Lixivaptan 64 superficial bladder cancer 64 docetaxel Taxotere ® 64 Tyrima 64 PNP inhibitor 64 Dasatinib 64 Gleevec imatinib 64 Archexin 64 OncoVEX GM CSF 64 Traficet EN 64 Kinoid 64 Aplidin 64 IRX 2 64 ancrod 64 multi kinase inhibitor 64 Aflibercept 64 vemurafenib 64 JAK inhibitor 64 SinuNase TM 64 radiation sensitizer 64 forodesine 64 CYT# potent vascular disrupting 64 Maribavir 64 generation purine nucleoside 64 OncoVEX 64 targeted radiotherapeutic 63 CCX# 63 investigational humanized monoclonal antibody 63 AEG# 63 Cloretazine 63 acetonide FA 63 metaglidasen 63 sunitinib Sutent 63 RhuDex ® 63 Tocosol Paclitaxel 63 mRCC 63 MAGE A3 ASCI 63 Dapagliflozin 63 cetuximab Erbitux R 63 chemotherapeutic drug 63 AQ4N 63 nucleoside analog 63 gastrointestinal stromal tumors GIST 63 Genentech Rituxan 63 SCH # 63 Carfilzomib 63 TNF inhibitor 63 systemically administered 63 triphendiol 63 TNF alpha inhibitor 63 Iluvien ® 63 vidofludimus 63 CIMZIA TM certolizumab pegol 63 dirucotide 63 Tarceva TM 63 humanised monoclonal antibody 63 mapatumumab 63 intranasal formulation 63 demonstrated antitumor activity 63 TG# [003] 63 synthetic retinoid 63 null responder 63 colorectal cancer liver metastases 63 histone deacetylase HDAC inhibitor 63 vascular disrupting agent 63 EGFR tyrosine kinase inhibitor 63 ESBA# 63 Phase #b/#a clinical 63 RSD# 63 Pazopanib 63 novel oral anticoagulant 63 VA# [002] 63 Vicinium TM 62 phase IIa clinical 62 XmAb# 62 sitaxsentan 62 VitiGam 62 dasatinib Sprycel ® 62 oral anticancer 62 BRAF inhibitors 62 thalidomide Thalomid 62 HCV protease inhibitors 62 alkylating agent 62 targeted antifolate 62 tafamidis 62 metastatic renal cell carcinoma 62 liposomal formulation 62 polymerase inhibitor 62 mertansine 62 TELINTRA 62 corticosteroid dexamethasone 62 Proxinium TM 62 cleavable linker 62 CDP# 62 immunotherapeutic vaccine 62 paclitaxel Taxol 62 Dacogen decitabine 62 hypoxia activated prodrug 62 edifoligide 62 DXL# 62 p# inhibitor 62 LymphoStat B belimumab 62 NV1FGF 62 microtubule inhibitor 62 cetuximab Erbitux ® 62 sorafenib Nexavar 62 SNT MC# 62 Irinotecan 62 EGFR TKI 62 Denufosol 62 OHR/AVR# 62 Pafuramidine 62 Allovectin 7 62 CD# monoclonal antibody 62 anticancer agent 62 invasive candidiasis 62 fluoropyrimidine 62 Factor VIIa 62 HBeAg negative 62 Simulect 62 concurrent chemoradiation 62 Factor Xa inhibitor 62 combinability 62 acute GvHD 62 PEGylated 62 oral methylnaltrexone 62 Amrubicin 62 GRN# 62 SERMs 62 Phase #b/#a trial 62 Aurora kinase inhibitor 62 chimeric monoclonal antibody 62 Nexavar sorafenib 62 humanized anti 62 Onconase 62 virus HCV protease inhibitor 62 BAY #-# 62 intravenous cyclophosphamide 62 Panzem R NCD 62 Sutent sunitinib 62 hypomethylating agents 62 metastatic RCC 62 elacytarabine 62 Dalbavancin 62 tumors GIST 62 TNFa 62 Fibrillex TM 62 PrevOnco 61 CINTREDEKIN BESUDOTOX 61 CBLC# 61 Actimmune ® 61 LymphoStat B TM 61 MGd 61 mTOR inhibitors 61 lenalidomide Revlimid R 61 either acutely decompensated 61 tyrosine kinase inhibitor TKI 61 Certolizumab pegol 61 epithelial tumors 61 ribavirin RBV 61 ATL# [001] 61 Ozarelix 61 TAFA# 61 anti TNF alpha 61 Vernakalant 61 TBC# 61 LHRH antagonist 61 lenalidomide dexamethasone 61 CytoFabTM 61 Rezular 61 acyclovir Lauriad R 61 novel histone deacetylase 61 oral JAK1 61 therapeutic monoclonal antibody 61 OvaRex ® MAb 61 FOLFOX6 61 TLK# 61 relapsed MM 61 delafloxacin 61 Personalized Immunotherapy 61 PI3K inhibitor 61 Anavex #-# 61 ribavirin therapy 61 HDACi 61 selective antagonist 61 PSN# [002] 61 lumiliximab 61 Velcade bortezomib 61 antisense inhibitors 61 Deforolimus 61 VALSTAR 61 IAP inhibitors 61 elotuzumab 61 peripherally acting 61 PRT# 61 Bicifadine 61 anticancer compound 61 Insegia 61 ENMD # 61 adalimumab Humira 61 YONDELIS 61 chemopreventive agent 61 protein kinase inhibitor 61 CDK inhibitor 61 Nanobody 61 CEQ# 61 CD# antibody [001] 61 isoform selective 61 ALGRX 61 HCD# [002] 61 MYDICAR ® 61 volociximab 61 TKI therapy 61 huC# DM4 61 Abatacept 61 CCR9 antagonist 61 Gefitinib 61 FUSILEV enhances 61 Novolimus 61 Anthim 61 antiproliferative effects 61 Gleevec resistant 61 Fludara ® 61 cilengitide 61 Aclidinium 61 Pradefovir 61 dalbavancin 61 investigational monoclonal antibody 61 ZOLINZA 61 imatinib Gleevec ® 61 carcinoma HCC 61 PEGylated Fab fragment 61 Pagoclone 61 Candesartan 61 fluoroquinolone antibiotic 61 Vidaza azacitidine 61 Sudhir Agrawal D.Phil 61 amrubicin 61 ALN TTR# 61 antiarrhythmic 61 proteasome inhibitors 61 Cleviprex TM clevidipine 61 ALN TTR 61 reslizumab 61 Cethromycin 61 signal transduction inhibitor 61 metastatic malignant 61 ELACYT 61 USL# 61 noninfectious uveitis 61 Alequel 61 S/GSK# 61 administered subcutaneously 61 VersaFilm 61 dacetuzumab 61 UPLYSO 61 DOS# 61 nucleotide analogue 61 Panzem 61 Erlotinib 61 MAXY G# 61 recurrent glioblastoma 61 indibulin 61 Octreotide 61 Temsirolimus 61 EGS# 60 recurrent GBM 60 goserelin 60 humanized antibody 60 Romidepsin 60 factor Xa inhibitor 60 trastuzumab DM1 60 fosbretabulin 60 Vidofludimus 60 Tolvaptan 60 HCV protease inhibitor 60 gepirone ER 60 OvaRex R 60 Zingo TM 60 recurrent glioblastoma multiforme 60 BRAF inhibitor 60 non nucleoside 60 Safinamide 60 Rituxan rituximab 60 anti angiogenic agent 60 Bucindolol 60 HuLuc# 60 Cloretazine VNP#M 60 leukemia AML 60 erlotinib Tarceva 60 rEV# 60 ILUVIEN ® 60 pegylated 60 caspofungin 60 torezolid 60 TriRima 60 nalbuphine ER 60 antisense drug 60 ANG# 60 otelixizumab 60 calcineurin inhibitor 60 orally bioavailable 60 Aganocide 60 aripiprazole Abilify 60 Squalamine 60 temsirolimus 60 echinocandins 60 Relivar 60 OncoVex 60 TLR8 agonist 60 HCV NS5B polymerase 60 Tamibarotene 60 refractory acute myeloid 60 etanercept Enbrel 60 Xanafide 60 antiangiogenic agent 60 ganciclovir 60 budesonide foam 60 PORxin TM 60 PI3 kinase inhibitors 60 castrate resistant prostate cancer 60 Afatinib 60 LEP ETU 60 Tolamba 60 orally administered inhibitor 60 hormone LHRH antagonist 60 ATL/TV# 60 TNF antagonist 60 Lubiprostone 60 daptomycin 60 Vorinostat 60 Solazed 60 humanized monoclonal 60 obatoclax 60 anthracycline taxane 60 ocular formulation 60 trastuzumab DM1 T DM1 60 EndoTAG TM -1 60 Oxytrex TM 60 HRPC 60 PI3K inhibitors 60 Peginterferon alfa 2b 60 Allovectin 7 ® 60 ulimorelin 60 REMUNE R 60 Octreolin 60 MEK inhibitors 60 posaconazole 60 Pimavanserin 60 omega interferon 60 BiTE 60 histone deacetylase HDAC 60 TRV# [001] 60 Vascugel 60 #D#C# 60 pharmacokinetic PK study 60 MKC# MKC# PP 60 VEGF inhibitors 60 PEGylated interferon 60 Zenvia ™ 60 dirucotide MBP# 60 methylnaltrexone 60 DU #b 60 Radezolid 60 dexanabinol 60 systemic fungal infections 60 Targretin 60 vascular disrupting agents 60 dexamethasone Decadron 60 tyrosine kinase inhibitor 60 NP2 Enkephalin 60 Reverset 60 oncolytic 60 AP# [003] 60 Collategene 60 oxidative stress inducer 60 Sphingomab TM 60 taxane chemotherapy 60 SPRYCEL ® 60 ISF# 60 LBH# 60 alvespimycin 60 SUTENT ® 60 GSK# [001] 60 Chemophase 60 EGFR inhibitors 60 Vascular Wrap TM 60 drug zotarolimus 60 small molecule Hedgehog 60 PI3K/Akt pathway inhibitor 60 biliary tract cancer 60 rBChE 60 IL# PE#QQR 60 efaproxiral 60 Hsp# inhibition 60 IAP inhibitor 60 imatinib mesylate 60 immunotherapeutic agent 60 SERCA2a 60 Exelixis compounds 60 verteporfin 60 vinca alkaloid 60 oral antiviral 60 evaluating tivozanib 60 investigational therapies 60 Adentri 60 VivaGel TM 60 BrachySil 60 cangrelor 60 BiTE antibody 60 Inhaled nitric oxide 60 TRX1 60 GLP toxicology studies 60 somatostatin analogue 60 flavopiridol 60 metastatic hormone refractory 60 recurrent herpes labialis 60 intradermal injection 60 immunomodulator 60 IIa trial 60 IMiDs R 60 Transdrug ® nanoparticle 60 midstage trials 60 nucleotide analog 60 micafungin 60 JAK2 inhibitor 60 ponatinib 60 pan HDAC inhibitor 60 ATPace TM 60 ADP receptor antagonist 60 Myocet 60 Alocrest 60 nucleotide analogs 60 Troxatyl 60 orally dosed 60 Elacytarabine 60 Omacetaxine 60 Hedgehog antagonist 60 pharmacokinetic interactions 60 antiangiogenesis 60 Phase IIb clinical trials 59 EGFR TKIs 59 HDAC Inhibitor 59 aldehyde dehydrogenase ALDH2 deficiency 59 vinorelbine tartrate 59 pertuzumab 59 Liprotamase 59 Zybrestat 59 estramustine 59 #mg QD [001] 59 BrachySil ™ 59 Pegloticase 59 pegylated interferon alpha 59 neuroprotectant 59 E2F Decoy 59 pradefovir 59 immunotoxin 59 depsipeptide 59 Hedgehog Pathway Inhibitor 59 alefacept 59 HQK 59 ceftazidime 59 Darusentan 59 Resten NG 59 CCR5 inhibitor 59 Alvesco R 59 weekly subcutaneous injections 59 lomitapide 59 Orally administered 59 non nucleoside inhibitor 59 aerosolized KL4 surfactant 59 dose cohort 59 antibody MAb 59 hepatic fibrosis 59 selective modulator 59 Vilazodone 59 TYZEKA 59 recombinant adeno associated 59 Vicriviroc 59 Adenoscan 59 MKC# MT 59 ixabepilone 59 Zolinza 59 EDEMA3 trial 59 Herceptin trastuzumab 59 CIMZIA TM 59 castration resistant prostate cancer 59 small molecule activators 59 oral ridaforolimus 59 glatiramer 59 MT#/MEDI-# 59 Fc fusion protein 59 Granulocyte Colony Stimulating Factor 59 motesanib 59 HuMax CD4 59 rALLy 59 Belerofon 59 uric acid lowering 59 EOquin 59 LEUKINE 59 metastatic bladder 59 DDP# 59 nucleoside analogue 59 KIACTA ™ 59 Anticalin R 59 peptide conjugated 59 Bosutinib 59 erlotinib Tarceva ® 59 AERx ® 59 peg interferon 59 CLORETAZINE TM VNP#M 59 Interferon alpha 59 LNPs 59 oral rivaroxaban 59 Gleevec imatinib mesylate 59 gefitinib Iressa 59 INS# [001] 59 Annamycin 59 histone deacetylase inhibitor 59 cMET 59 Valdoxan 59 SinuNase 59 tipifarnib 59 candidate TNFerade biologic 59 GEM OS2 59 plasmid encoding 59 IMC A# 59 NXL# 59 fusion inhibitor 59 allogeneic HSCT 59 Luteinizing Hormone Releasing Hormone 59 cysteamine bitartrate 59 methotrexate therapy 59 PF # [002] 59 anthracycline therapy 59 dexpramipexole 59 axitinib 59 Anti VEGF 59 idarubicin 59 assessing T DM1 59 generation antisense inhibitor 59 Intravenous CP 59 cannabinor 59 prokinetic 59 Pertuzumab 59 Atrasentan 59 glucokinase activator 59 Ketotransdel 59 LE DT 59 fluocinolone acetonide 59 systemic RNAi therapeutic 59 AKT inhibitor 59 vernakalant hydrochloride 59 RezularTM 59 PSMA ADC 59 cidofovir 59 BNC# 59 Nanobodies 59 Vidaza R 59 Hsp# inhibitor 59 including eniluracil ADH 59 HGS ETR2 59 BCR ABL inhibitor 59 nanoviricide 59 talactoferrin 59 Achieves Primary Endpoint 59 Golimumab 59 Laquinimod 59 selective kinase inhibitor 59 Zenapax 59 REP# 59 tezampanel NGX# 59 Firazyr 59 Panzem R 59 ORENCIA ® 59 oral taxane 59 HCV RESPOND 2 59 AGILECT R 59 thienopyridines 59 small molecule thrombopoietin 59 choroidal vasculopathy 59 ganaxolone 59 Symadex 59 Ventavis ® 59 INTEGRILIN ® 59 visilizumab 59 Allovectin 7 R 59 Deferiprone 59 Clolar ® 59 adenoviral 59 teriflunomide 59 adenosine injection 59 Degarelix 59 vascular disrupting 59 Telintra 59 phase IIb III 59 multitargeted 59 HSP# inhibitor 59 immune modulator 59 AzaSite Plus 59 Ganciclovir 59 BZL# 59 PEG SN# 59 rituximab Rituxan 59 histone deacetylase HDAC inhibitors 59 Diamyd ® 59 alkylating agents 59 effector function 59 DermaVir Patch 59 pomalidomide 59 bexarotene 59 regorafenib 59 tubulin inhibitor 59 IMC #B 59 drug ISA# 59 TOCOSOL Camptothecin 59 trastuzumab Herceptin ® 59 Epratuzumab 59 advanced metastatic renal 59 Optiquel ™ 59 TKM ApoB 59 lucinactant 59 cathepsin K inhibitor 59 SinuNase ™ 59 Virulizin ® 59 Hsp# Inhibitor 59 zotarolimus 59 enzyme inhibitor 59 gemcitabine Gemzar ® 59 gastrointestinal stromal tumor GIST 59 GW# [003] 59 tolevamer 59 CRLX# 59 gastrointestinal stromal tumors 59 Pemetrexed 59 Cloretazine R 59 CHOP chemotherapy 59 hepatitis C HCV 59 Doripenem 59 postoperative ileus 59 TroVax ® 59 Lupuzor 59 TransMID 59 Onrigin 59 nilotinib Tasigna ® 59 panitumumab Vectibix 59 GnRH antagonist 59 ARIKACE ™ 59 MyVax 59 BEMA TM Fentanyl 59 alpha blocker 59 cell lymphoma CTCL 59 eosinophilic asthma 59 CIMZIA ™ 58 trabectedin 58 CA4P 58 CTAP# Capsules 58 anthracyclines taxanes 58 epothilone 58 phase IIb trial 58 Bicalutamide 58 Pfizer Sutent 58 busulfan 58 GV# [001] 58 Epothilones 58 biologic therapy 58 Nanobody ® 58 Aptivus ® 58 polycythemia vera essential thrombocythemia 58 Aurora kinase 58 ara C 58 tigecycline 58 ketolide antibiotic 58 entinostat 58 Locked Nucleic Acid LNA 58 molecular imaging radiopharmaceutical 58 myeloid metaplasia 58 refractory gout 58 antiangiogenic therapy 58 Daclizumab 58 oral salmon calcitonin 58 metastatic HRPC 58 Sapacitabine 58 ProSavin 58 paclitaxel Taxol ® 58 Diabetic Macular Edema DME 58 ospemifene 58 selective orally bioavailable 58 Aviptadil 58 neurologic progression 58 beta interferons 58 antithrombotic 58 MAb 58 mitogen activated ERK kinase 58 CG# [003] 58 dasatinib Sprycel 58 GAMMAGARD 58 JAK inhibitors 58 anti infective treatments 58 lupus nephritis 58 Alzhemed TM 58 Retisert 58 afamelanotide 58 MTP inhibitor 58 punctal plug delivery 58 cytostatic 58 Quinamed 58 multiple myeloma MM 58 alpha interferon 58 sodium glucose cotransporter 58 direct thrombin inhibitors 58 Civacir 58 relapsed ovarian cancer 58 oral beclomethasone dipropionate 58 bevacizumab Avastin ® 58 lapatinib Tykerb 58 INT# [002] 58 PHX# 58 Exherin TM 58 Eculizumab 58 Azedra 58 mTOR inhibition 58 AMPK activators 58 ONCONASE R 58 MYDICAR 58 investigational protease inhibitor 58 PROCHYMAL 58 Pyridorin 58 ATL# [002] 58 allogeneic cell 58 Phase Ib study 58 HCV polymerase 58 Prosaptide 58 HepDirect prodrug 58 LHRH agonists 58 thetreatment 58 Phase 1a clinical 58 cardiotoxic 58 Silodosin 58 T#I [002] 58 Hepatitis C HCV 58 Tykerb lapatinib 58 virotherapy 58 PLX cells 58 anti EGFR antibody 58 Cethrin R 58 Ceflatonin 58 TOCOSOL 58 octreotide acetate 58 Brinavess 58 intravesical instillation 58 anticancer therapy 58 Uricase PEG 58 NEUGENE 58 stage IIIB 58 recurrent malignant glioma 58 rxRNA 58 HepaMate 58 antiangiogenic 58 Navelbine ® 58 trial evaluating PRX# 58 lintuzumab SGN 58 accumulate preferentially 58 TH# [003] 58 Enzastaurin 58 Preclinical studies suggest 58 Hedgehog pathway inhibitor 58 Fingolimod 58 Fibrillex 58 subcutaneous formulation 58 refractory colorectal cancer 58 cytotoxic chemotherapy 58 bispecific antibody 58 non metastatic osteosarcoma 58 Lenocta 58 BCR ABL inhibitors 58 Tesetaxel 58 ruxolitinib 58 Amplimexon 58 steroid refractory 58 INCB# [001] 58 vapreotide acetate 58 Phase 2b study 58 Oral NKTR 58 R#/MEM # 58 TRO# 58 TLR9 agonist 58 LPLD 58 Genasense ® 58 alfa 2a 58 Acute Radiation Syndrome ARS 58 Debio 58 successfully commercialize Iluvien 58 humanized monoclonal antibodies 58 inhibit replication 58 gemcitabine Gemzar 58 ciprofloxacin hydrochloride 58 Gemzar gemcitabine 58 achieve sustained virologic 58 aurora kinase 58 antimitotic 58 SCCHN 58 ACTEMRA TM 58 mediated inhibition 58 protease inhibitor PI 58 PSN# [001] 58 anticancer activity 58 Teriflunomide 58 immunoconjugate 58 patientswith 58 MAXY alpha 58 CANCIDAS 58 EVIZON TM 58 beta estradiol 58 Urocidin 58 Dyloject TM 58 M# rationally 58 arbaclofen 58 ALK inhibitors 58 paclitaxel Taxol R 58 Cx# [002] 58 Mycograb 58 angiogenesis inhibitor 58 esophageal candidiasis 58 zileuton 58 amphotericin B 58 XL# XL# 58 RH1 58 peptidomimetic 58 A1PI 58 Darinaparsin 58 kinase inhibitor 58 selective androgen receptor modulator 58 ORENCIA R 58 immunosuppressant drug 58 EndoTAG 58 Chemokine Receptor 58 pemphigus vulgaris 58 Curaxin 58 Anticalins R 58 IMP# 58 Lauriad ® 58 metastatic sarcoma 58 immunological diseases 58 bicifadine 58 vosaroxin 58 FOLFOX6 chemotherapy regimen 58 cytoprotective 58 selective receptor agonist 58 phase Ib 58 SAR# [004] 58 intra arterial chemotherapy 58 ASONEP TM 58 oxymorphone ER 58 Atu# 58 HBeAg positive 58 tivozanib 58 Fibrin Pad 58 HFA MDI 58 active comparator 58 ALV# 58 adipiplon 58 Telbivudine 58 NS4A 58 Pharmacokinetics PK 58 Viprinex TM 58 refractory chronic lymphocytic 58 MICARDIS ® 58 alpha interferons 58 ularitide 58 sJIA 58 Akt activation 58 imatinib Gleevec 58 human IgG1 monoclonal 58 rALLy clinical trial 58 Pralatrexate 58 interferon alfa 58 Fodosine 58 bardoxolone 58 anti amnesic 58 novel VDA molecule 58 PEG IFN 58 BRIM2 58 HyACT 58 Aurexis 58 MVA BN 58 Clofarabine 58 Lpathomab 58 cancer vaccine Norelin 58 Solulin 58 KSP inhibitor 58 Tarvacin TM 58 Kevetrin ™ 58 PTH analogue 58 Provecta TM 58 investigational hepatitis C 58 Crofelemer 58 GRNVAC1 58 evaluating CK # 58 EXPAREL TM 58 romidepsin 58 Aurora Kinase 58 Xcytrin 58 personalized immunotherapy 58 calcineurin inhibitors 58 refractory CTCL 58 Blinatumomab 58 Nexavar ® 58 hypervascular tumors 58 torezolid phosphate 58 retinal vein occlusion induced 58 RhuDex 58 cisplatin gemcitabine 58 nucleoside reverse transcriptase inhibitor 58 Interferon beta 58 vismodegib 58 ASONEP ™ 58 Diabetic Macular Edema 58 Vfend 58 mycophenolate mofetil 58 LY# [003] 58 PEG interferon 58 Eraxis 58 DermaVir 58 fibrotic disease 58 siRNAs targeting 58 p# inhibitors 58 taxane therapy 58 neratinib 58 anti CD3 58 Microplasmin 58 sd rxRNA 58 Ophena 58 MyVax R 58 albiglutide 58 methylnaltrexone bromide 58 2DG 58 selective agonist 58 Atypical Hemolytic Uremic Syndrome 58 nosocomial pneumonia 58 Levoleucovorin 58 IGF IR 57 clodronate 57 Omnitarg 57 nucleoside analogs 57 Hsp# inhibitors 57 Cloretazine R VNP#M 57 mutant KRAS 57 inhibit EGFR 57 anti CD# antibody 57 relapsing remitting MS RRMS 57 Torisel 57 anagrelide 57 lexidronam injection 57 monoclonal antibody mAb 57 Raptiva ® 57 oral antiplatelet 57 5 HT3 antagonist 57 Thiarabine 57 PrevOnco ™ 57 colorectal liver metastases 57 immune modulatory 57 GVAX ® 57 antibody fragment 57 Phase Ib II 57 Phase 1b clinical 57 tumorigenicity 57 compound perifosine 57 INCB# [002] 57 Motesanib 57 QuadraSphere 57 HepeX B 57 luteinizing hormone releasing 57 antitumor effect 57 zafirlukast